跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TARO-RIVAROXABAN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TARO-RIVAROXABAN
Authorized
STANDARD
TARO-RIVAROXABAN
Taro Pharmaceuticals Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
6e2b54ea230deb19
Company
Taro Pharmaceuticals Inc
Type
Standard
Approval Details
Approval Id
6e2b54ea230deb19
Drug Approval Canada Name
TARO-RIVAROXABAN
Product Name
TARO-RIVAROXABAN
Status
Marketed
Status Date
2023-11-01
Original Market Date
2023-11-01
Din
02526786
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
20:12.04.14
Atc Original
B01AF01 RIVAROXABAN
Atc Name
b 01 af 01
Aig Number
0152487004
Company Name
Taro Pharmaceuticals Inc
Company Address
130 East Drive, Brampton, Ontario, Canada, L6T 1C1
Company Detail Path
/organization/taro-pharmaceuticals-inc
Company Information
Pharmaceutical Company Name
Taro Pharmaceuticals Inc
Country Name
Canada
Province Name
Ontario
City Name
brampton,ontario,country_ca
Address
130 East Dr
Active Ingredients
RIVAROXABAN
2.5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
6e2b54ea230deb19
Type
Standard
Back to Health Canada Approvals